EN DE
STOCK COMPARISON

Buhpf vs HCA Healthcare: Fair Value & Quality

Both stocks run through our valuation models. Here is how Buhpf (BUHPF) and HCA Healthcare (HCA) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Buhpf trades at $5.45 versus a fair value of $4.68 (-14%), while HCA Healthcare trades at $413 versus $555 (+34%).
Buhpf
BUHPF · USD · Health Care
-14%
upside to fair value
overvalued
Price$5.45
Fair Value$4.68
Quality70/100
HCA Healthcare
HCA · USD · Health Care
+34%
upside to fair value
undervalued
Price$413
Fair Value$555
Quality70/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

BuhpfHCA Healthcare
Valuation
20.2×P/E (TTM)12.5×
—P/S (TTM)1.06×
—EV/EBITDA7.8×
7.36×PEG1.18×
—Dividend yield0.8%
$5.00Dividend per share$2.94
Profitability
30%Net margin9%
35%Operating margin15%
24%Return on equity136%
16%Return on assets12%
Growth
1%Revenue growth (YoY)4%
6.6%Avg. growth/yr (3Y)7.9%
15.2%Avg. growth/yr (5Y)8.0%
Balance & size
0.00×Debt / equity—
$4BMarket cap$81B
mixedGrowth qualityhealthy

HCA Healthcare leads: 4 to 5 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Buhpfof which business quality 70 · market factors 46 HCA Healthcareof which business quality 66 · market factors 46
ProfitabilityMargins and returns on capital today
79
76
Quality GrowthAre margins and returns improving?
20
61
CashflowEarnings quality: real cash, not paper profit
78
62
Fin. StrengthBalance sheet, leverage, solvency risk
93
39
InvestmentDisciplined investing over empire-building
39
75
Low VolatilityCalm price path (market factor)
50
59
MomentumPrice trend over the last 3–12 months (market factor)
41
38
52W MomentumDistance to the 52-week high (market factor)
49
44
Net IssuanceBuybacks instead of dilution
82
100

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Buhpf

DCF Models$4.39
Earnings-Based$2.26
Dividend Discount$2.31
Multiples$5.11
Asset-Based$0.77
Growth DCF$3.75
Economic Profit$2.75
Growth Earnings$5.22

23 of 26 models see the stock below the current price.

HCA Healthcare

DCF Models$546
Earnings-Based$289
Dividend Discount$53.85
Multiples$673
Growth DCF$540
Economic Profit$419
Growth Earnings$506

6 of 23 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Buhpf
Bear $3.13Fair Value $4.68Bull $6.25
$5.45 = current price (white tick)
HCA Healthcare
Bear $270Fair Value $555Bull $841
$413 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Buhpf · Health Care

Quality score70 · Top 25%
Fair value upside-14% · above median

HCA Healthcare · Health Care

Quality score70 · Top 25%
Fair value upside+34% · Top 25%

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Buhpf trades at $5.45 versus a fair value of $4.68 (-14%), while HCA Healthcare trades at $413 versus $555 (+34%).

Buhpf has the higher quality score (70/100).

See the full analysis →
Buhpf · HCA Healthcare

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Buhpf

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company

Related to HCA Healthcare

UnitedHealth Group vs AstraZenecaUnitedHealth Group vs Thermo Fisher ScientificUnitedHealth Group vs AmgenUnitedHealth Group vs Abbott Laboratories
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.